Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Amicus Therapeutics - Stock Price History | FOLD

Historical daily share price chart and data for Amicus Therapeutics since 2019 adjusted for splits. The latest closing stock price for Amicus Therapeutics as of November 19, 2019 is 9.76.
  • The all-time high Amicus Therapeutics stock closing price was 18.23 on September 14, 2015.
  • The Amicus Therapeutics 52-week high stock price is 14.62, which is 49.8% above the current share price.
  • The Amicus Therapeutics 52-week low stock price is 7.11, which is 27.2% below the current share price.
  • The average Amicus Therapeutics stock price for the last 52 weeks is 11.24.
  
Amicus Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 13.8221 15.1600 17.1200 8.3800 9.5800 -33.43%
2017 10.3500 5.1300 16.2400 5.1300 14.3900 189.54%
2016 6.9360 9.0300 9.3500 4.5300 4.9700 -48.76%
2015 11.4110 8.6100 18.2300 5.9500 9.7000 16.59%
2014 4.2658 2.4100 8.6100 1.8200 8.3200 254.04%
2013 2.7800 2.8400 4.2200 1.9700 2.3500 -12.31%
2012 5.2648 3.5700 6.8800 2.5300 2.6800 -22.09%
2011 5.3292 4.5600 7.9400 2.1000 3.4400 -26.81%
2010 3.4267 3.8400 4.8000 1.9500 4.7000 18.39%
2009 7.9094 8.0000 12.2700 3.3600 3.9700 -50.25%
2008 11.2884 10.3400 17.9500 7.5000 7.9800 -25.77%
2007 13.8496 14.4300 18.0400 9.5400 10.7500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.441B $0.091B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.118B 15.10
CSL (CSLLY) Australia $83.969B 0.00
Gilead Sciences (GILD) United States $81.336B 10.08
Celgene (CELG) United States $77.805B 11.11
Vertex Pharmaceuticals (VRTX) United States $54.001B 55.12
Biogen (BIIB) United States $50.996B 8.75
Illumina (ILMN) United States $45.080B 49.46
Regeneron Pharmaceuticals (REGN) United States $37.351B 16.35
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.893B 11.80
Seattle Genetics (SGEN) United States $19.834B 0.00
Incyte (INCY) United States $18.845B 43.74
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
Genmab (GNMSF) Denmark $14.056B 62.08
BioMarin Pharmaceutical (BMRN) United States $13.502B 0.00
Exact Sciences (EXAS) United States $10.667B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.338B 0.00
Galapagos (GLPG) Belgium $10.332B 26.62
BeiGene (BGNE) Cayman Islands $9.307B 0.00
QIAGEN (QGEN) Netherlands $9.257B 30.18
Amarin (AMRN) Ireland $8.073B 0.00
Bio-Techne Corp (TECH) United States $8.058B 53.93
Guardant Health (GH) United States $7.399B 0.00
Sarepta Therapeutics (SRPT) United States $7.298B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.942B 0.00
Moderna (MRNA) United States $6.482B 0.00
Reata Pharmaceuticals (RETA) United States $6.275B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.755B 14.63
ARGENX SE-ADR (ARGX) Netherlands $5.392B 0.00
Exelixis (EXEL) United States $4.931B 13.87
Medicines (MDCO) United States $4.676B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
Ascendis Pharma (ASND) Denmark $4.508B 0.00
Repligen (RGEN) United States $4.499B 81.54
Spark Therapeutics (ONCE) United States $4.282B 0.00
Bluebird Bio (BLUE) United States $4.150B 0.00
Adaptive Biotechnologies (ADPT) United States $3.748B 0.00
Blueprint Medicines (BPMC) United States $3.668B 0.00
Mirati Therapeutics (MRTX) United States $3.653B 0.00
MorphoSys AG (MOR) Germany $3.563B 0.00
Immunomedics (IMMU) United States $3.442B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.231B 0.00
Alkermes (ALKS) Ireland $3.176B 0.00
Genmab (GMAB) Denmark $2.923B 6.02
Emergent Biosolutions (EBS) United States $2.806B 27.87
Halozyme Therapeutics (HALO) United States $2.767B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.717B 0.00
NeoGenomics (NEO) United States $2.532B 134.72
MyoKardia (MYOK) United States $2.497B 0.00
UniQure (QURE) Netherlands $2.314B 0.00
Arena Pharmaceuticals (ARNA) United States $2.266B 5.27
Acceleron Pharma (XLRN) United States $2.255B 0.00
Zai Lab (ZLAB) China $2.251B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.121B 0.00
Cambrex (CBM) United States $2.017B 25.46
Myriad Genetics (MYGN) United States $1.841B 27.20
Ligand Pharmaceuticals (LGND) United States $1.818B 34.97
Insmed (INSM) United States $1.797B 0.00
Akcea Therapeutics (AKCA) United States $1.762B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.514B 0.00
Zymeworks (ZYME) Canada $1.465B 0.00
Denali Therapeutics (DNLI) United States $1.464B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.464B 0.00
Epizyme (EPZM) United States $1.404B 0.00
REGENXBIO (RGNX) United States $1.377B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.350B 0.00
Coherus BioSciences (CHRS) United States $1.345B 0.00
Innoviva (INVA) United States $1.267B 3.73
Editas Medicine (EDIT) United States $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Zealand Pharma (ZEAL) Denmark $1.161B 0.00
Alector (ALEC) United States $1.094B 0.00
Sangamo Therapeutics (SGMO) United States $1.083B 0.00
Fate Therapeutics (FATE) United States $1.081B 0.00
Arvinas (ARVN) United States $1.048B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.997B 0.00
WAVE Life Sciences (WVE) Singapore $0.980B 0.00
Principia Biopharma (PRNB) United States $0.954B 0.00
Athenex (ATNX) United States $0.887B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Codexis (CDXS) United States $0.865B 0.00
Anika Therapeutics (ANIK) United States $0.857B 27.82
Cara Therapeutics (CARA) United States $0.847B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.830B 6.98
Vericel (VCEL) United States $0.824B 307.17
ZIOPHARM Oncology Inc (ZIOP) United States $0.816B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.721B 184.16
Revance Therapeutics (RVNC) United States $0.719B 0.00
Twist Bioscience (TWST) United States $0.691B 0.00
ANI Pharmaceuticals (ANIP) United States $0.678B 11.56
DBV Technologies S.A (DBVT) France $0.671B 0.00
Intellia Therapeutics (NTLA) United States $0.665B 0.00
MiMedx (MDXG) United States $0.653B 0.00
Precision BioSciences (DTIL) United States $0.643B 0.00
Agenus (AGEN) United States $0.604B 0.00
Mesoblast (MESO) Australia $0.601B 0.00
Adverum Biotechnologies (ADVM) United States $0.590B 0.00
GENFIT S.A (GNFT) France $0.580B 0.00
Cellectis S.A (CLLS) France $0.565B 0.00
Retrophin (RTRX) United States $0.559B 0.00
BioDelivery Sciences (BDSI) United States $0.545B 0.00
UROGEN PHARMA (URGN) United States $0.545B 0.00
Kadmon Holdings (KDMN) United States $0.536B 0.00
Stemline Therapeutics (STML) United States $0.525B 0.00
Cytokineticsorporated (CYTK) United States $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.493B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.479B 0.00
Intra-Cellular Therapies (ITCI) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.476B 11.02
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.409B 0.00
Clovis Oncology (CLVS) United States $0.387B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.375B 2.60
Merus (MRUS) Netherlands $0.366B 0.00
Bellus Health (BLU) Canada $0.364B 0.00
Cellular Biomedicine (CBMG) United States $0.349B 0.00
PDL BioPharma (PDLI) United States $0.344B 8.60
Arcus Biosciences (RCUS) United States $0.336B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.326B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.305B 0.00
AnaptysBio (ANAB) United States $0.301B 0.00
Compugen (CGEN) Israel $0.293B 0.00
Avid Bioservices (CDMO) United States $0.291B 0.00
Kindred Biosciences (KIN) United States $0.288B 0.00
Protagonist Therapeutics (PTGX) United States $0.278B 0.00
Pfenex (PFNX) United States $0.270B 0.00
Sutro Biopharma (STRO) United States $0.263B 0.00
Cel-Sci (CVM) United States $0.261B 0.00
Gritstone Oncology (GRTS) United States $0.261B 0.00
Seres Therapeutics (MCRB) United States $0.256B 0.00
Geron (GERN) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.07
MannKind (MNKD) United States $0.248B 0.00
Theratechnologies (THTX) Canada $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
Kamada (KMDA) Israel $0.239B 6.98
OSMOTICA PHARM (OSMT) United States $0.238B 0.00
CytomX Therapeutics (CTMX) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.232B 0.00
Inovio Pharmaceuticals (INO) United States $0.228B 0.00
XOMA (XOMA) United States $0.226B 0.00
Albireo Pharma (ALBO) United States $0.225B 0.00
Athersys (ATHX) United States $0.218B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
Scholar Rock Holding (SRRK) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Cue Biopharma (CUE) United States $0.209B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Sorrento Therapeutics (SRNE) United States $0.194B 0.00
Exicure (XCUR) United States $0.187B 0.00
Affimed (AFMD) Germany $0.185B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.184B 0.00
Spero Therapeutics (SPRO) United States $0.181B 0.00
Palatin Technologies (PTN) United States $0.180B 4.91
CorMedix Inc (CRMD) United States $0.173B 0.00
Dyadic (DYAI) United States $0.171B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.168B 0.00
Arsanis (XFOR) United States $0.165B 0.00
Senesco Technologies (ELOX) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Alcobra (ARCT) United States $0.147B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Cerecor (CERC) United States $0.137B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Fortress Biotech (FBIO) United States $0.133B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.131B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
BioTime (LCTX) United States $0.130B 6.65
Ophthotech (ISEE) United States $0.125B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Five Prime Therapeutics (FPRX) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
NantKwest (NK) United States $0.112B 0.00
Aptinyx (APTX) United States $0.106B 0.00
OvaScience (MLND) United States $0.106B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
VBI Vaccines (VBIV) United States $0.106B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Novavax (NVAX) United States $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
Celyad SA (CYAD) Belgium $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Aduro Biotech (ADRO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.080B 0.00
Strongbridge Biopharma (SBBP) United States $0.080B 2.13
Acorda Therapeutics (ACOR) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Selecta Biosciences (SELB) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Verastem (VSTM) United States $0.064B 0.00
Synlogic (SYBX) United States $0.063B 0.00
Trevena (TRVN) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Checkpoint Therapeutics (CKPT) United States $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Orgenesis (ORGS) United States $0.053B 3.39
China Health Industries Holdings (CHHE) China $0.052B 15.78
Applied Genetic Technologies (AGTC) United States $0.051B 0.00
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Curis (CRIS) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Celsion (CLSN) United States $0.032B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.56
VIVUS (VVUS) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
VistaGen Therapeutics (VTGN) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Advaxis (ADXS) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.003B 0.00
Neuralstem (SNCA) United States $0.002B 0.00